iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Narrative) (Details)

Stockholders' Equity (Narrative) (Details)	Dec. 01, 2022 shares	Oct. 07, 2022	Aug. 23, 2022 shares	May 09, 2022 USD ($) $ / shares shares	Oct. 31, 2021 $ / shares	Feb. 23, 2017 USD ($) shares	Dec. 31, 2022 $ / shares shares	Dec. 06, 2022 shares	Jul. 19, 2022 shares	Jun. 30, 2022 $ / shares shares	Nov. 01, 2021 $ / shares shares
Stockholders' Equity [Line Items]
Preferred Stock, shares authorized				1,000,000		1,000,000	1,000,000			1,000,000
Preferred stock, shares outstanding (in shares)							0			1,000
Preferred stock, par value (in dollars per share) \| $ / shares				$ 0.001			$ 0.001			$ 0.001
Common stock, shares authorized (in shares)							275,000,000			275,000,000
Stockholders' Equity Note, Stock Split, Conversion Ratio		0.04
College Station Investors LLC And Bryan Capital [Member]
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares											$ 33.25
Warrants to purchase shares of Common Stock											51,583
H.C. Wainwright & Co., LLC [Member]
Stockholders' Equity [Line Items]
Warrants to purchase shares of Common Stock								201,923
Pre Funded Warrants [Member] \| H.C. Wainwright & Co., LLC [Member]
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares							$ 0.001
Series A Warrants [Member] \| H.C. Wainwright & Co., LLC [Member]
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares							$ 1.04
Term of the warrants							5 years
Warrants to purchase shares of Common Stock								504,807
Series B Warrants [Member] \| H.C. Wainwright & Co., LLC [Member]
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares							$ 1.04
Term of the warrants							2 years
Warrants to purchase shares of Common Stock								504,807
Representative Warrants [Member] \| H.C. Wainwright & Co., LLC [Member]
Stockholders' Equity [Line Items]
Warrants, exercise price per share \| $ / shares							$ 1.30
Term of the warrants							5 years
iBio CMO Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Dividend Rate, Percentage						2.00%
Preferred Stock, Dividends Per Share, Declared \| $ / shares					$ 0
Preferred stock, shares outstanding (in shares)											0
Series 2022 Convertible Preferred Stock [Member]
Stockholders' Equity [Line Items]
Proceeds from sale of shares, net of issuance cost \| $				$ 270
Shares issued upon conversion									40
Shares issued				1,000
Stockholders' Equity Note, Stock Split, Conversion Ratio				1
Restricted Stock Units [Member]
Stockholders' Equity [Line Items]
Shares vested	4,120		1,057
Omnibus Incentive (the 2020) Plan [Member]
Stockholders' Equity [Line Items]
Shares available for grant under the plan							1,280,000
Exchange Agreement [Member] \| iBio CMO Preferred Tracking Stock [Member] \| Bioprocessing (iBio CDMO) [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, Acquisitions						1
Number of LLC interest units exchanged for each share of preferred tracking stock						29,990,000
Proceeds from sale of shares, net of issuance cost \| $						$ 13,000,000
Exchange Agreement [Member] \| iBio CMO Preferred Tracking Stock [Member] \| After Preferred Tracking Stock Exchanged for Units of Limited Liability Company Interests [Member] \| Bioprocessing (iBio CDMO) [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent						99.99%
Exchange Agreement [Member] \| Eastern Affiliate [Member] \| iBio CMO Preferred Tracking Stock [Member] \| After Preferred Tracking Stock Exchanged for Units of Limited Liability Company Interests [Member] \| Bioprocessing (iBio CDMO) [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners						0.01%